The Detrimental Effects of Adrenocorticosteroid Therapy in Hbsag–Positive Chronic Active Hepatitis: Fact or Artifact?
Open Access
- 1 November 1982
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 2 (6), 885-887
- https://doi.org/10.1002/hep.1840020625
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITISThe Lancet, 1980
- Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.Gut, 1980
- Randomised trial of steroid therapy in acute liver failure. Report from the European Association for the Study of the Liver (EASL).Gut, 1979
- Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.Gut, 1976
- Randomization of Corticosteroid Therapy in Fulminant HepatitisNew England Journal of Medicine, 1976
- Steroid Therapy in Severe Viral HepatitisNew England Journal of Medicine, 1976
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973
- Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQJM: An International Journal of Medicine, 1971
- ADRENAL HORMONE THERAPY IN VIRAL HEPATITIS. II. THE EFFECT OF CORTISONE IN THE ACUTE DISEASEAnnals of Internal Medicine, 1953